Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-02-12
1994-08-16
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514269, 514303, 514312, 514334, 514340, 514342, 514361, 514363, A61K 31435, A61K 3142
Patent
active
053387376
ABSTRACT:
Novel heterocyclic methyl derivatives of biphenyl oxadiazoles and thiadiazoles are described, as well as methods for the preparation of said derivatives and pharmaceutical compositions of the same, which are useful as antagonists of the angiotensin II enzyme and thus useful in treating hypertension, hyperaldosteronism, congestive heart failure, and glaucoma.
REFERENCES:
patent: 4618617 (1986-10-01), Yamamoto
patent: 5086053 (1992-02-01), Brodin et al.
patent: 5100897 (1992-03-01), Allen et al.
patent: 5102897 (1992-04-01), Boschelli et al.
Connor David T.
Kostlan Catherine R.
Ashbrook Charles W.
Daignault Ronald A.
Dentz Bernard
Warner-Lambert & Company
LandOfFree
Biphenyl oxadiazoles and thiadiazoles as angiotensin II antagoni does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biphenyl oxadiazoles and thiadiazoles as angiotensin II antagoni, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biphenyl oxadiazoles and thiadiazoles as angiotensin II antagoni will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-951988